Cargando…

Mismatch repair protein and MLH1 methylation status as predictors of response to adjuvant therapy in endometrial cancer

BACKGROUND: Mismatch repair (MMR) system has been implicated in the response of mammalian cells to ionizing radiation and DNA damaging agents. We investigated the value of the MMR system in predicting response to adjuvant therapy in endometrial cancer. METHODS: This was a single institution retrospe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Loukovaara, Mikko, Pasanen, Annukka, Bützow, Ralf
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Clinical Cancer Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7897956/ https://www.ncbi.nlm.nih.gov/pubmed/33449452 http://dx.doi.org/10.1002/cam4.3691

Ejemplares similares

Mismatch Repair Deficiency as a Predictive and Prognostic Biomarker in Molecularly Classified Endometrial Carcinoma
por: Loukovaara, Mikko, et al.
Publicado: (2021)

Testing for Lynch Syndrome in Endometrial Carcinoma: From Universal to Age-Selective MLH1 Methylation Analysis
por: Pasanen, Annukka, et al.
Publicado: (2022)

Clinicopathologic vs. Molecular Integrated Prognostication of Endometrial Carcinoma by European Guidelines
por: Loukovaara, Mikko, et al.
Publicado: (2022)

Interpretable prognostic modeling of endometrial cancer
por: Zagidullin, Bulat, et al.
Publicado: (2022)

Differential impact of clinicopathological risk factors within the 2 largest ProMisE molecular subgroups of endometrial carcinoma
por: Pasanen, Annukka, et al.
Publicado: (2021)

Clinical factors as prognostic variables among molecular subgroups of endometrial cancer
por: Kolehmainen, Anne, et al.
Publicado: (2020)

Low Expression of Stanniocalcin 1 (STC-1) Protein Is Associated With Poor Clinicopathologic Features of Endometrial Cancer
por: Khatun, Masuma, et al.
Publicado: (2021)

Altered glycosylation of glycodelin in endometrial carcinoma
por: Hautala, Laura C., et al.
Publicado: (2020)

FIGO 1988 versus 2009 staging for endometrial carcinoma: a comparative study on prediction of survival and stage distribution according to histologic subtype
por: Haltia, Ulla-Maija, et al.
Publicado: (2014)

MLH1 promoter hypermethylation predicts poorer prognosis in mismatch repair deficiency endometrial carcinomas
por: Kaneko, Enami, et al.
Publicado: (2021)

Contribution of MLH1 constitutional methylation for Lynch syndrome diagnosis in patients with tumor MLH1 downregulation
por: Pinto, Diana, et al.
Publicado: (2018)

Impact of age and mismatch repair status on survival in colorectal cancer
por: Li, Pan, et al.
Publicado: (2017)

Detection of microsatellite instability with Idylla MSI assay in colorectal and endometrial cancer
por: Ukkola, Iiris, et al.
Publicado: (2021)

DNA Mismatch Repair Protein Immunohistochemistry and MLH1 Promotor Methylation Testing for Practical Molecular Classification and the Prediction of Prognosis in Endometrial Cancer
por: Kim, Jisup, et al.
Publicado: (2018)

Advances in genetic technologies result in improved diagnosis of mismatch repair deficiency in colorectal and endometrial cancers
por: Evans, D Gareth, et al.
Publicado: (2022)

Mlh2 Is an Accessory Factor for DNA Mismatch Repair in Saccharomyces cerevisiae
por: Campbell, Christopher S., et al.
Publicado: (2014)

Mutational Analysis of Mismatch Repair Genes, hMLH1 and hMSH2, in Sporadic Endometrial Carcinomas with Microsatellite Instability
por: Kobayashi, Kanji, et al.
Publicado: (1996)

Mismatch repair status between primary colorectal tumor and metastatic tumor, a retrospective consistent study
por: Wang, Zheng, et al.
Publicado: (2019)

Clinical activity of durvalumab for patients with advanced mismatch repair-deficient and repair-proficient endometrial cancer. A nonrandomized phase 2 clinical trial
por: Antill, Yoland, et al.
Publicado: (2021)

Mismatch Repair Genes Mlh1 and Mlh3 Modify CAG Instability in Huntington's Disease Mice: Genome-Wide and Candidate Approaches
por: Pinto, Ricardo Mouro, et al.
Publicado: (2013)

The mismatch repair and meiotic recombination endonuclease Mlh1-Mlh3 is activated by polymer formation and can cleave DNA substrates in trans
por: Manhart, Carol M., et al.
Publicado: (2017)

DNA mismatch repair gene MLH1 induces apoptosis in prostate cancer cells
por: Fukuhara, Shinichiro, et al.
Publicado: (2014)

Handcuffing intrinsically disordered regions in Mlh1–Pms1 disrupts mismatch repair
por: Furman, Christopher M, et al.
Publicado: (2021)

Prevalence of Lynch syndrome in women with mismatch repair‐deficient ovarian cancer
por: Hodan, Rachel, et al.
Publicado: (2020)

Comparison of Methods for Testing Mismatch Repair Status in Endometrial Cancer
por: Mendiola, Marta, et al.
Publicado: (2023)

Spectrum of DNA mismatch repair failures viewed through the lens of cancer genomics and implications for therapy
por: Mas-Ponte, David, et al.
Publicado: (2022)

Colorectal tumour BRAF V600E and MLH1 promoter methylation status in the assessment of mismatch repair gene sequence variants of unknown clinical significance
por: Parsons, M, et al.
Publicado: (2012)

Assessment of mismatch repair deficiency in ovarian cancer
por: Crosbie, Emma J, et al.
Publicado: (2021)

Mutations in the MutSα interaction interface of MLH1 can abolish DNA mismatch repair
por: Plotz, Guido, et al.
Publicado: (2006)

Functional implications of the p.Cys680Arg mutation in the MLH1 mismatch repair protein
por: Dominguez-Valentin, Mev, et al.
Publicado: (2014)

Estrogen enhances mismatch repair by induction of MLH1 expression via estrogen receptor-β
por: Lu, Jun-Yu, et al.
Publicado: (2017)

Mlh1 interacts with both Msh2 and Msh6 for recruitment during mismatch repair
por: DuPrie, Matthew L., et al.
Publicado: (2022)

Germline mismatch repair gene variants analyzed by universal sequencing in Japanese cancer patients
por: Kiyozumi, Yoshimi, et al.
Publicado: (2019)

MED12 mutations and fumarate hydratase inactivation in uterine adenomyomas
por: Heikkinen, Tuomas, et al.
Publicado: (2018)

Combination of primary tumor location and mismatch repair status guides adjuvant chemotherapy in stage II colon cancer
por: Yang, Lin, et al.
Publicado: (2017)

Rad9 plays an important role in DNA mismatch repair through physical interaction with MLH1
por: He, Wei, et al.
Publicado: (2008)

Activation of Saccharomyces cerevisiae Mlh1-Pms1 Endonuclease in a Reconstituted Mismatch Repair System
por: Smith, Catherine E., et al.
Publicado: (2015)

DNA mismatch repair protein Mlh1 is required for tetravalent chromium intermediate-induced DNA damage
por: Wakeman, Timothy P., et al.
Publicado: (2017)

Identification of MLH2/hPMS1 dominant mutations that prevent DNA mismatch repair function
por: Reyes, Gloria X., et al.
Publicado: (2020)

Lymphadenectomy and adjuvant therapy in endometrial carcinoma: role of adjuvant chemotherapy
por: Otsuka, I, et al.
Publicado: (2002)

Cannot write session to /tmp/vufind_sessions/sess_5dco0uee3j8ua2g9adsqcn5i6r